Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-a. (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7554/elife.52668

PubMed Identifier: 32091388

Publication URI: http://europepmc.org/abstract/MED/32091388

Type: Journal Article/Review

Volume: 9

Parent Publication: eLife

ISSN: 2050-084X